Suppr超能文献

[凝血因子XII缺乏症的遗传学]

[The genetics of factor XII deficiency].

作者信息

Kempter B, Rüth S, Epple I, Lohse P

机构信息

Institut für Klinische Chemie, Klinikum Grosshadern, München, BRD.

出版信息

Beitr Infusionsther. 1993;31:174-8.

PMID:7693250
Abstract

There are two main forms of factor XII deficiency: patients with immunological cross-reacting material (CRM+) and patients without (CRM-). For 1 case of CRM+ an amino acid substitution (Cys571-->Ser) has been described. We are currently investigating two families of Hageman CRM- trait with the typical hemostaseological pattern: one member with virtually no factor XII activity and antigen, whose sisters and children have about 50% of activity and antigen. To elucidate the genetic defect, primers were synthesized for both exon-intron borders for each of the 14 exons. Polymerase chain reaction (PCR) was performed for each single exon and for any two exons in a row with the intron in between (double-exon screening). We were able to demonstrate that homozygous patients do not have major rearrangements, deletions or insertions of the factor XII gene. To localize the molecular defect, the complete gene was sequenced by cloning the PCR products into pBS. In 1 patient, a single base deletion in exon 12, leading to a nonsense protein, was detected. The propositus was shown to be heterozygous for this defect by a deletion-specific restriction fragment length polymorphism of the PCR product.

摘要

凝血因子XII缺乏主要有两种形式:有免疫交叉反应物质的患者(CRM+)和没有免疫交叉反应物质的患者(CRM-)。对于1例CRM+患者,已描述了一种氨基酸替代(Cys571→Ser)。我们目前正在研究两个具有典型止血模式的Hageman CRM-特征家族:一名成员几乎没有凝血因子XII活性和抗原,其姐妹和子女的活性和抗原约为50%。为了阐明基因缺陷,针对14个外显子的每个外显子-内含子边界合成了引物。对每个单个外显子以及连续的任意两个外显子(中间有内含子)进行聚合酶链反应(PCR)(双外显子筛选)。我们能够证明纯合患者没有凝血因子XII基因的重大重排、缺失或插入。为了定位分子缺陷,通过将PCR产物克隆到pBS中对完整基因进行测序。在1例患者中,检测到外显子12中的单个碱基缺失,导致无义蛋白。通过PCR产物的缺失特异性限制性片段长度多态性显示先证者对此缺陷为杂合子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验